Literature DB >> 12787639

Nanoparticles bearing polyethyleneglycol-coupled transferrin as gene carriers: preparation and in vitro evaluation.

Yaping Li1, Manfred Ogris, Ernst Wagner, Jaroslav Pelisek, Martina Rüffer.   

Abstract

The aims of this work were to determine the stability of pDNA against various conditions during microencapsulation, prepare transferrin (TF)-conjugated PEGylated polycyanoacrylate nanoparticles (TF-PEG-nanoparticles), and assess its physicochemical characteristics and in vitro targeting cells association. The open circular forms of pDNA obviously increased when pDNA was emulsified into organic solution under sonification. When pDNA solution (pH 7.0) contained 1, 3 or 5% (w/v) PVA, after sonification, average 48.2, 59.4 and 62.1% of double-supercoiled DNA (dsDNA) were preserved, respectively. When medium of pDNA was 0.9% NaCl (pH 7.0), 0.1M NaHCO(3) (pH 8.0) or phosphate buffer (pH 8.0), average 53.1, 69.3 and 56.9% of dsDNA remained after sonification, respectively. Poly(aminopoly(ethylene glycol)cyanoacrylate-co-hexadecyl cyanoacrylate) (poly(H(2)NPEGCA-co-HDCA)) showed a slight influence on pDNA in 0.1M NaHCO(3) (pH 8.0) when its concentration increased from 0.5 to 4% (w/v). TF-PEG-nanoparticles loading pDNA were spherical in shape with size under 200nm and entrapment efficiency 35-50%. 0.1M NaHCO(3) with 3% PVA (w/v) could largely reduce the damage of pDNA during microencapsulation. TF-PEG-nanoparticles bore 1-3% of the total PEG chains conjugated to TF molecules, and exhibited the burst effect with over 30% drug release within 1 day. After the first phase, pDNA release profiles displayed a sustained release. The amount of cumulated pDNA release over 7 days was: 86.3, 81.5 and 74.4% for 1, 2 and 4% polymer nanoparticles, respectively. The degree of target K562 cell binding of TF-PEG-nanoparticles was greater than that of non-targeted PEG-nanoparticles at 4 degrees C. The presence of free TF decreased significantly the degree of cell binding of TF-PEG-nanoparticles, which revealed that the binding of TF-PEG-nanoparticles to K562 cells was indeed receptor specific. These results suggested that TF-PEG-nanoparticles were useful for delivery of pDNA to target cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787639     DOI: 10.1016/s0378-5173(03)00211-4

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  11 in total

1.  Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.

Authors:  Jiang Chang; Archibald Paillard; Catherine Passirani; Marie Morille; Jean-Pierre Benoit; Didier Betbeder; Emmanuel Garcion
Journal:  Pharm Res       Date:  2011-12-14       Impact factor: 4.200

2.  Paclitaxel-loaded poly(n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer.

Authors:  Fei Ren; Ruda Chen; Ying Wang; Yabin Sun; Yaodong Jiang; Guofeng Li
Journal:  Pharm Res       Date:  2010-12-24       Impact factor: 4.200

3.  Binding and uptake of wheat germ agglutinin-grafted PLGA-nanospheres by caco-2 monolayers.

Authors:  Andrea Weissenboeck; Elisabeth Bogner; Michael Wirth; Franz Gabor
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

4.  cAMP-Coupled riboflavin trafficking in placental trophoblasts: a dynamic and ordered process.

Authors:  Vanessa M D'Souza; Amy B Foraker; R Benjamin Free; Abhijit Ray; Paul S Shapiro; Peter W Swaan
Journal:  Biochemistry       Date:  2006-05-16       Impact factor: 3.162

Review 5.  The transferrin receptor and the targeted delivery of therapeutic agents against cancer.

Authors:  Tracy R Daniels; Ezequiel Bernabeu; José A Rodríguez; Shabnum Patel; Maggie Kozman; Diego A Chiappetta; Eggehard Holler; Julia Y Ljubimova; Gustavo Helguera; Manuel L Penichet
Journal:  Biochim Biophys Acta       Date:  2011-08-05

6.  Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model.

Authors:  Goldie Kaul; Mansoor Amiji
Journal:  J Drug Target       Date:  2004       Impact factor: 5.121

7.  Nanoparticle formulations that allow for sustained delivery and brain targeting of the neuropeptide oxytocin.

Authors:  Rokon Uz Zaman; Nihal S Mulla; Keegan Braz Gomes; Cherilyn D'Souza; Kevin Sean Murnane; Martin J D'Souza
Journal:  Int J Pharm       Date:  2018-07-19       Impact factor: 5.875

8.  Novel pentablock copolymers for selective gene delivery to cancer cells.

Authors:  Bingqi Zhang; Mathumai Kanapathipillai; Paul Bisso; Surya Mallapragada
Journal:  Pharm Res       Date:  2009-01-14       Impact factor: 4.200

9.  OX26 modified hyperbranched polyglycerol-conjugated poly(lactic-co-glycolic acid) nanoparticles: synthesis, characterization and evaluation of its brain delivery ability.

Authors:  Hanmei Bao; Xu Jin; Ling Li; Feng Lv; Tianjun Liu
Journal:  J Mater Sci Mater Med       Date:  2012-05-09       Impact factor: 3.896

10.  Nanoparticle encapsulation increases the brain penetrance and duration of action of intranasal oxytocin.

Authors:  Aboagyewaah Oppong-Damoah; Rokon Uz Zaman; Martin J D'Souza; Kevin Sean Murnane
Journal:  Horm Behav       Date:  2018-12-30       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.